The results of treatment with idarubicin in childhood acute nonlymphoblastic leukemia


Sasmaz I. , Tanyeli A., Bayram I. , Antmen B. , Yilmaz L. , Kucukosmanoglu O., ...More

TURKISH JOURNAL OF PEDIATRICS, vol.46, no.1, pp.32-37, 2004 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 46 Issue: 1
  • Publication Date: 2004
  • Title of Journal : TURKISH JOURNAL OF PEDIATRICS
  • Page Numbers: pp.32-37

Abstract

Anthracycline and cytosine arabinoside are used in combination as the standard therapy for remission induction of acute nonlymphoblastic leukemia. Idarubicin, a synthetic daunorubicin analogue, shows an improved spectrum activity and diminishes acute or chronic toxicity when compared with the other anthracyclines. This study has been carried out in our clinic in order to evaluate the efficiency of the acute nonlymphoblastic leukemia protocol which includes idarubicin.